Molecular analyses of the platelet glycoprotein Ib-IX-V receptor

Thrombosis and Haemostasis

Volumn 79, Issue 3, 1998, Pages 466-478

  Ware, Jerry ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; GLYCOPROTEIN IB; LEUCINE; MEMBRANE RECEPTOR; THROMBOCYTE RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; EXON; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; MEGAKARYOCYTE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; THROMBOCYTE;

EID: 0031886074     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614928     Document Type: Review

References (154)

1. Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci USA 1987; 84: 5610-4.
2. 2-glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-9.
3. Lopez JA, Chung DW, Fujikawa K, Hagen FS, Davie EW, Roth GJ. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci USA 1988; 85: 2135-9.
4. Hickey MJ, Williams SA, Roth GJ. Human platelet glycoprotein IX: An adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci USA 1989; 86: 6773-7.
5. Hickey MJ, Hagen FS, Yagi M, Roth GJ. Human platelet glycoprotein V: Characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci USA 1993; 90: 8327-31.
6. Lanza F, Morales M, La Salle C, Cazenave J, Clemetson KJ, Shimomura T, Phillips DR. Cloning and characterization of the gene encoding the human platelet glycoprotein V. J Biol Chem 1993; 268: 20801-7.
7. Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AEGK. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992; 267: 364-9.
8. Meyer S, Kresbach G, Haring P, Schumpp-Vonach B, Clemetson KJ, Hadvary P, Steiner B. Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. Incorporation of GP Ib alpha into the cell surface membrane. J Biol Chem 1993; 268: 20555-62.
9. Lopez JA, Leung B, Reynolds CC, Li CQ, Fox JEB. Efficient plasma membrane expression of a functional platelet glycoprotein Ib-IX complex requires the presence of its three subunits. J Biol Chem 1992; 267: 12851-9.
10. Calverley DC, Yagi M, Stray SM, Roth GJ. Human platelet glycoprotein V: its role in enhancing expression of the glycoprotein Ib receptor. Blood 1995; 86: 1361-7.
11. Meyer SC, Fox JE. Interaction of platelet glycoprotein V with glycoprotein Ib-IX regulates expression of the glycoproteins and binding of von Willebrand factor to glycoprotein Ib-IX in transfected cells. J Biol Chem 1995; 270: 14693-9.
12. Wenger RH, Wicki AN, Kieffer N, Adolph S, Hameister H, Clemetson KJ. The 5' flanking region and chromosomal localization of the gene encoding human platelet membrane glycoprotein Ibα. Gene 1989; 85: 517-24.
13. Yagi M, Edelhoff S, Disteche CM, Roth GJ. Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ibβ. J Biol Chem 1994; 269: 17424-7.
14. Kelly MD, Essex DW, Shapiro SS, Meloni FJ, Druck T, Huebner K, Konkle BA. Complementary DNA cloning of the alternatively expressed endothelial cell glycoprotein Ibβ (GPIbβ) and localization of the GPIbβ gene to chromosome 22. J Clin Invest 1994; 93: 2417-24.
15. Yagi M, Edelhoff S, Disteche CM, Roth GJ. Human platelet glycoproteins V and IX: mapping of two leucine-rich glycoprotein genes to chromosome 3 and analysis of structures. Biochemistry 1995; 34: 16132-7.
16. Ware J, Russell S, Ruggeri ZM. Cloning of the murine platelet glycoprotein Ibα gene highlighting species-specific platelet adhesion. BCMD 1997; 23: 292-301.
17. Ravanat C, Morales M, Azorsa DO, Moog S, Schuler S, Grunert P, Loew D, Van Dorsselaer A, Cazenave J-P, Lanza F. Gene cloning of rat and mouse platelet glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 1997; 89: 3253-62.
18. Kitaguchi T, Murata M, Anbo H, Moriki T, Ikeda Y. Characterization of the gene encoding mouse platelet glycoprotein Ibβ. Throm Res 1997; 87: 235-44.
19. Hashimoto Y, Ware J. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Iba gene. J Biol Chem 1995; 270: 24532-9.
20. Bastian LS, Yagi M, Chan C, Roth GJ. Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites. J Biol Chem 1996; 271: 18554-60.
21. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/ silencer domain and the GATA site. Mol Cell Biol 1991; 11: 6116-27.
22. Uzan G, Prenant M, Prandini M, Martin F, Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 1991; 266: 8932-9.
23. Block KL, Ravid K, Phung QH, Poncz M. Characterization of regulatory elements in the 5'-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. Blood 1994; 84: 3385-93.
24. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 22076-80.
25. Orkin SH. Transcription factors and hematopoietic development. J Biol Chem 1995; 270 (10): 4955-8.
26. Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80: 575-81.
27. Leonard M, Brice M, Engel JD, Papayannopoulou T. Dynamics of GATA transcription factor expression dunng erythroid differentiation. Blood 1993; 82: 1071-9.
28. Aird WC, Parvin JD, Sharp PA, Rosenberg RD. The interaction of GATA-binding proteins and basal transcription factors with GATA box-containing core promoters. A model of tissue-specific gene expression. J Biol Chem 1994; 269: 883-9.
29. Fong AM, Santoro SA. Transcriptional regulation of alpha IIb integrin gene expression during megakaryocytic differentiation of K562 cells. Role of a silencer element. J Biol Chem 1994; 269: 18441-7.
30. Prandini MH, Martin F, Thevenon D, Uzan G. The tissue-specific transcriptional regulation of the megakaryocytic glycoprotein IIb gene is controlled by interactions between a repressor and positive cis-acting elements. Blood 1996; 88: 2062-70.
31. Martin P, Papayannopoulou T. HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233-5.
32. Papayannopoulou T, Nakamoto B, Kurachi S, Tweeddale M, Messner H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. Blood 1988; 72: 1029-38.
33. Tabilio A, Rosa J-P, Testa U, Kieffer N, Nurden AT, Del Canizo MC, Breton-Gorius J, Nainchenker W. Expression of platelet membrane glycoproteins and α-granule proteins by human erythroleukemia cell line (HEL). EMBO J 1994; 3: 453-9.
34. Konkle BA, Shapiro SS, Asch AS, Nachman RL. Cytokine-enhanced expression of glycoprotein Ibα in human endothelium. J Biol Chem 1990; 265: 19833-8.
35. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA. Tumor necrosis factor-α modulation of glycoprotein Ibα expression in human endothelial and erythroleukemia cells. Blood 1992; 80: 153-61.
36. Wu G, Essex DW, Meloni FJ, Takafuta T, Fujimura K, Konkle BA, Shapiro SS. Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 1997; 90: 2660-9.
37. Perrault C, Lankhof H, Pidard D, Kerbiriou-Nabias D, Sixma JJ, Meyer D, Baruch D. Relative importance of the glycoprotein Ib-binding domain and the RGD sequence of von Willebrand factor for its interaction with endothelial cells. Blood 1997; 90: 2335-44.
38. Liaw L, Schwartz SM. Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Differences in growth regulatory molecules. Arteriosclerosis & Thrombosis 1993; 13: 985-93.
39. Zieger B, Hashimoto Y, Ware J. Alternative expression of platelet glycoprotein Ibβ mRNA from an adjacent 5' gene with an imperfect polyadenylation signal sequence. J Clin Invest 1997; 99: 520-5.
40. Kozak M. The scanning model for translation: an update. J Cell Biol 1989; 108: 229-41.
41. Mountford PS, Smith AG. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. Trends Genet 1995; 11: 179-84.
42. Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood 1987; 69: 1524-7.
43. Berndt MC, Gregory C, Kabral A, Zola H, Fournier D, Castaldi PA. Purification and preliminary characterization of glycoprotein Ib complex in the human platelet membrane. Eur J Biochem 1985; 151: 637-49.
44. Okumura T, Jamieson GA. Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem 1976; 251: 5944-9.
45. Okumura T, Lombart C, Jamieson GA. Platelet glycocalicin. II. Purification and characterization. J Biol Chem 1976; 251: 5950-5.
46. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986; 261: 12579-85.
47. Vicente V, Kostel PJ, Ruggeri ZM. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His(1)-Arg(293) of the alpha-chain of glycoprotein Ib. J Biol Chem 1988; 263: 18473-9.
48. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an α-thrombin-binding site on platelet glycoprotein Ibα. J Biol Chem 1994; 269: 6478-84.
49. Murata M, Ware J, Ruggeri ZM. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ibα demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991; 266: 15474-80.
50. Hess D, Schaller J, Rickli EE, Clemetson KJ. Identification of the disulphide bonds in human platelet glycocalicin. Eur J Biochem 1991; 199: 389-93.
51. Korrel SAM, Clemetson KJ, van Halbeek H, Kamerling JP, Sixma JJ, Vliegenthart JFG. Identification of a tetrasialylated monofucosylated tetraantennary N-linked carbohydrate chain in human platelet glycocalicin. Febs Lett 1988; 228: 321-6.
52. Tsuji T, Osawa T. The carbohydrate moiety of human platelet glycocalicin. The structures of the major Asn-linked sugar chains. J Biochem 1987; 101: 241-9.
53. Roth GJ. Developing Relationships: Arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood 1991; 77: 5-19.
54. Dong J, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: Identification of sulfated residues and effect on ligand binding. Biochemistry J 1994; 33: 13946-53.
55. Marchese P, Murata M, Mazzucato M, Pradella P, De Marco L, Ware J, Ruggeri ZM. Identification of three tyrosine residues of glycoprotein Ibα with distinct roles in von Willebrand factor and α-thrombin binding. J Biol Chem 1995; 270: 9571-8.
56. Fox JEB. Linkage of a membrane skeleton to integral membrane glycoprotein in human platelets. Identification of one of the glycoproteins as glycoprotein Ib. J Clin Invest 1985; 76: 1673-83.
57. Fox JEB. Identification of actin-binding protein as the protein linking the membrane skeleton to glycoproteins on platelet plasma membranes. J Biol Chem 1985; 260: 11970-7.
58. Aakhus AM, Wilkinson JM, Solum NO. Binding of human platelet glycoprotein Ib and actin to fragments of actin-binding protein. Thromb Haemost 1992; 67: 252-7.
59. Andrews RK, Fox JE. Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein. J Biol Chem 1992; 267: 18605-11.
60. Du X, Harris SJ, Tetaz TJ, Ginsberg MH, Berndt MC. Association of a phospholipase A2 (14-3-3 protein) with the platelet glycoprotein Ib-IX complex. J Biol Chem 1994; 269: 18287-90.
61. Du X, Fox JE, Pei S. Identification of a binding sequence for the 14-3-3 protein within the cytoplasmic domain of the adhesion receptor, platelet glycoprotein Ib alpha. J Biol Chem 1996; 271: 7362-7.
62. Wang W, Shakes DC. Molecular evolution of the 14-3-3 protein family. J Mol Evol 1996; 43: 384-98.
63. Muszbek L, Laposata M. Glycoprotein Ib and glycoprotein IX in human platelets are acylated with palmitic acid through thioester linkages. J Biol Chem 1989; 264: 9716-9.
64. Wyler B, Bienz D, Clemetson KJ, Luscher EF. Glycoprotein Ib beta is the only phosphorylated major membrane glycoprotein in human platelets. Biochem J 1986; 234: 373-9.
65. Wardell MR, Reynolds CC, Berndt MC, Wallace RW, Fox JEB. Platelet glycoprotein Ib beta is phosphorylated on serine 166 by cyclic AMP-dependent protein kinase. J Biol Chem 1989; 264: 15656-61.
66. McGowan EB, Ding A, Detwiler TC. Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J Biol Chem 1983; 258: 11243-8.
67. Phillips DR, Poh Agin P. Platelet plasma membrane glycoproteins: evidence for the presence of nonequivalent disulfide bonds using non-reduced reduced two-dimensional gel electrophoresis. J Biol Chem 1977; 252: 2121-6.
68. Mosher DF, Vaheri A, Choate JJ, Gahmberg CG. Action of thrombin on surface glycoproteins of human platelets. Blood 1979; 53: 437-45.
69. Takahashi N, Takahashi Y, Putnam FW. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci USA 1985; 82: 1906-10.
70. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 1993; 366: 751-6.
71. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Bioch Sci 1994; 19: 415-21.
72. Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 1995; 374: 183-6.
73. Koo YB, Ji I, Slaughter RG, Ji TH. Structure of the luteinizing hormone receptor gene and multiple exons of the coding sequence. Endocrinology 1991; 128: 2297-308.
74. Wenger RH, Kieffer N, Wicki AN, Clemetson KJ. Structure of the human blood platelet membrane glycoprotein Ib alpha gene. Biochem Biophys Res Commun 1988; 156: 389-95.
75. Hickey MJ, Roth GJ. Characterization of the gene encoding human platelet glycoprotein IX. J Biol Chem 1993; 268: 3438-3443
76. Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990; 265: 274-80.
77. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
78. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-6.
79. Miller JL, Kupinski JM, Castella A, Ruggeri ZM. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983; 72: 1532-42.
80. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J. 1993; 7: 308-16.
81. Cruz MA, Petersen E, Turci SM, Handin RI. Functional analysis of a recombinant glycoprotein Ibα polypeptide which inhibits von Willebrand factor binding to the platelet glyocportein Ib-IX complex and to collagen. J Biol Chem 1992; 267: 1303-9.
82. Meyer S, Kresbach G, Haring P, Schumpp-Vonach B, Clemetson KJ, Hadvary P, Steiner B. Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. J Biol Chem 1993; 268: 20555-62.
83. Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib. Thromb Haemost 1990; 63: 122-6.
84. Ware J, Russell SR, Marchese P, Murata M, Mazzucato M, De Marco L, Ruggeri ZM. Point mutation in a leucine-rich repeat of platelet glycoprotein Ibα resulting in the Bernard-Soulier syndrome. J Clin Invest 1993; 92: 1213-20.
85. Vu TH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
86. Hung DT, Vu TH, Wheaton VI, Ishii K, Coughlin SR. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89: 1350-3.
87. Brass LF, Vassallo RR Jr, Belmonte E, Ahuja M, Cichowski K, Hoxie JA. Structure and function of the human platelet thrombin receptor. J Biol Chem 1992; 267: 13795-8.
88. Harmon JT, Jamieson GA. Thrombin binds to a high-affinity ∼900,000-dalton site on human platelets. Biochemistry 1985; 24: 58-64.
89. Harmon JT, Jamieson GA. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 1986; 261: 13224-9.
90. Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Throm Res 1991; 62: 673-84.
91. De Marco L, Mazzucato M, Masotti A, Fenton JW II, Ruggeri ZM. Function of glycoprotein Ibα in platelet activation induced by α-thrombin. J Biol Chem 1991; 266: 23776-83.
92. Michelson AD, Barnard MR. Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 1987; 70: 1673-8.
93. Michelson AD, Ellis PA, Barnard MR, Malic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound. Blood 1991; 77 (4): 770-9.
94. George JN, Torres MM. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. Blood 1988; 71: 1253-9.
95. Kovacsovics TJ, Hartwig JH. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation. Blood 1996; 87: 618-29.
96. White JG, Krumwiede MD, Cocking-Johnson D, Rao GH, Escolar G. Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. Blood 1995; 86: 3468-78.
97. White JG, Krumwiede MD, Cocking-Johnson DJ, Escolar G. Uptake of vWF-anti-vWF complexes by platelets in suspension. Art Thromb Vas Biol 1996; 16: 868-77.
98. Rao GH, Peller JD, White JG. Influence of ionized calcium on thrombin-induced down regulation of GPIb/IX receptors on human platelets. Throm Res 1997; 85: 23-31.
99. Loscalzo J, Inbal A, Handin RI. von Willebrand protein facilitates platelet incorporation in polymerizing fibrin. J Clin Invest 1986; 78: 1112-9.
100. Parker RI, Gralnick HR. Fibrin monomer induces binding of endogenous platelet von Willebrand factor to glycocalicin portion of platelet glycoprotein Ib. Blood 1987; 70: 1589-94.
101. Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor platelet glycoprotein Ib. Thromb Haemost 1997; 76: 633-9.
102. Peng M, Lu W, Kirby EP. Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb Haemost 1992; 67: 702-7.
103. Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-8.
104. Peng M, Emig FA, Mao A, Lu W, Kirby EP, Niewiarowski S, Kowalska MA. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIβ. Thromb Haemost 1995; 74: 954-7.
105. Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 1995; 74: 743-50.
106. Nurden AT, Didry D, Rosa J-P. Molecular defects of platelets in Bernard-Soulier syndrome. Blood Cells 1983; 9: 333-58.
107. Kishimoto TK, Hollander N, Roberts TM, Anderson DC, Springer TA. Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency. Cell 1987; 50: 193-202.
108. O'Toole TE, Loftus JC, Plow EF, Glass AA, Harper JR, Ginsberg MH. Efficient surface expression of platelet GPIIb-IIIa requires both subunits. Blood 1989; 74: 14-8.
109. De Marco L, Mazzucato M, Fabris F, De Roia D, Coser P, Girolami A, Vicente V, Ruggeri ZM. Variant Bernard-Soulier syndrome type Bolzano: A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest 1990; 86: 25-31.
110. Budarf ML, Konkle BA, Ludlow LB, Michaud D, Li M, Yamashiro DJ, McDonald-McGinn D, Zackai EH, Driscoll DA. Identification of a patient with Bernard-Soulier syndrome and a deletion in the DiGeorge/velocardio-facial chromosomal region in 22q11.2. Hum Mol Genet 1995; 4: 763-6.
111. Andrews RK, Fox JEB. Interaction of purified human platelet actin-binding protein with membrane glycoprotein Ib-IX complex. Supplement to Circulation 1990; 82: III-597
112. Miller JL. Platelet-type von Willebrand disease. Thromb Haemost 1996; 75: 865-9.
113. Miller JL, Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 1982; 60: 790-4.
114. Murata M, Russell SR, Ruggeri ZM, Ware J. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombiant gycoprotein Ibα fragment. J Clin Invest 1993; 91: 2133-7.
115. Russell SD, Roth GJ. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. Blood 1993; 81: 1787-91.
116. Takahashi H, Murata M, Moriki T, Anbo H, Furukawa T, Nikkuni K, Shibata A, Handa M, Kawai Y, Watanabe K, et al. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease. Blood 1995; 85: 727-33.
117. Moriki T, Murata M, Kitaguchi T, Anbo H, Handa M, Watanabe K, Takahashi H, Ikeda Y. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239→Val) reported in patients with platelet-type von Willebrand disease. Blood 1997; 90: 698-705.
118. Moroi M, Jung SM, Yoshida N. Genetic polymorphism of platelet glycoprotein Ib. Blood 1984; 64: 622-9.
119. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem 1992; 267: 10055-61.
120. Ishida F, Furihata K, Ishida K, Yan J, Kitano K, Kiyosawa K, Furuta S. The largest variant of platelet glycoprotein Ib alpha has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145. Blood 1995; 86: 1357-60.
121. Judson PA, Anstee DJ, Clamp JR. Isolation and characterization of the major oligosaccharide of human platelet membrane glycoprotein GPIb. Biochem J 1982; 205: 81-90.
122. Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 1988; 263: 12820-3.
123. Gerard C, Eddy RL Jr, Shows TB. The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue. J Clin Invest 1990; 86: 1921-7.
124. Tsuji T, Tsunehisa S, Watanabe Y, Yamamoto K, Tohyama H, Osawa T. The carbohydrate moiety of human platelet glycocalicin. The structure of the major Ser/Thr-linked sugar chain. J Biol Chem 1983; 258: 6335-9.
125. Korrel SAM, Clemetson KJ, van Halbeek H, Kamerling JP, Sixma JJ, Vliegenthart JFG. Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. J Biochem 1984; 140: 571-6.
126. Korrel SAM, Clemetson KJ, van Halbeek H, Kamerling JP, Sixma JJ, Vliegenthart JFG. The structure of a fucose-containing O-glycosidic carbohydrate chain of human platelet glycocalicin. Glycoconjugate J 1985; 2: 229-34.
127. Fox JEB, Aggerbeck LP, Berndt MC. Structure of the glycoprotein Ib-IX complex from platelet membranes. J Biol Chem 1988; 263: 4882-90.
128. Kuijpers RWAM, Ouwehand WH, Bleeker PMM, Christie D, von dem Borne AEGK. Localization of the platelet-specific HPA-2 (Ko) alloantigens on the N-terminal globular fragment of platelet glycoprotein Ibα. Blood 1992; 79: 283-8.
129. Ishida F, Saji H, Maruya E, Furihata K. Human platelet-specific antigen, Siba, is associated with the molecular weight polymorphism of glycoprotein Ibα. Blood 1991; 78: 1722-9.
130. Kuijpers RWAM, Faber NM, Cuypers HTM, Ouwehand WH, von dem Borne AEGK. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine145/threonine145 amino acid polymorphism, which is associated with HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-4.
131. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refratoriness. Blood 1992; 79: 3086-90.
132. He R, Reid DM, Jones CE, Shulman NR. Extracellular epitopes of platelet glycoprotein Ib alpha reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura. Blood 1995; 86: 3789-96.
133. Kiefel V, Vicariot M, Giovangrandi Y, Kroll H, Bohringer M, Greinacher A, Breitfeld C, Santoso S, Mueller-Eckhardt C. Alloimmunization against Iy, a low-frequency antigen on platelet glycoprotein Ib/IX as a cause of severe neonatal alloimmune thrombocytopenic purpura. Vox Sanguinis 1995; 69: 250-4.
134. Li C, Pasquale DN, Roth GJ. Bernard-Soulier syndrome with severe bleeding: absent platelet glycoprotein Ib alpha due to a homozygous one-base deletion. Thromb Haemost 1997; 76: 670-4.
135. Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992; 79: 439-46.
136. Simsek S, Admiraal LG, Modderman PW, van der Schoot CE, von dem Borne AEGK. Identification of a homozygous single base pair deletion in the gene coding for the human platelet glycoprotein Ibα causing Bernard-Soulier syndrome. Thromb Haemost 1994; 72 (3): 444-9.
137. Li C, Martin SE, Roth GJ. The genetic defect in two well-studied cases of Bernard-Soulier syndrome: a point mutation in the fifth leucine-rich repeat of platelet glycoprotein Ib alpha. Blood 1995; 86: 3805-14.
138. de la Salle C, Baas MJ, Lanza F, Schwartz A, Hanau D, Chevalier J, Cachet C, Briquel ME, Cazenave JP. A three-base deletion removing a leucine residue in a leucine-rich repeat of platelet glycoprotein Ib alpha associated with a variant of Bernard-Soulier syndrome (Nancy I). Br J Haematol 1995; 89: 386-96.
139. Simsek S, Noris P, Lozano M, Pico M, Von dem Borne AE, Ribera A, Gallardo D. Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome. Br J Haematol 1994; 88: 839-44.
140. Kanaii T, Okamura T, Kurolwa M, Noda M, Fujimura K, Kuramoto A, Sano M, Nakano S, Niho Y. Molecular and genetic analysis of two patients with Bernard-Soulier syndrome - identification of new mutations in glycoprotein Ib alpha gene. Thromb Haemost 1997; 77: 1055-61.
141. Ware J, Russell SR, Vicente V, Scharf RE, Tomer A, McMillan R, Ruggeri ZM. Nonsense mutation in the glycoprotein Ibalpha coding sequence associated with Bernard-Soulier syndrome. Proc Natl Acad Sci USA 1990; 87: 2026-30.
142. Kunishima S, Miura H, Fukutani H, Yoshida H, Osumi K, Kobayashi S, Ohno R, Naoe T. Bernard-Soulier syndrome kagoshima: Ser 444 - stop mutation of glycoprotein (GP) Ibα resulting in circulating truncated GPIbα and surface expression of GPIbβ and GPIX. Blood 1994; 84: 3356-62.
143. Noda M, Fujimura K, Takafuta T, Shimomura T, Fujimoto T, Yamamoto N, Tanoue K, Arai M, Suehiro A, Kakishita E, et al. Heterogeneous expression of glycoprotein Ib, IX and V in platelets from two patients with Bernard-Soulier syndrome caused by different genetic abnormalities. Thromb Haemost 1995; 74: 1411-5.
144. Kenny D, Newman PJ, Morateck PA, Montgomery RR. A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ibα in a novel form of Bernard-Soulier syndrome. Blood 1997; 90: 2626-33.
145. Afshar-Kharghan V, Lopez JA. Bernard-Soulier syndrome caused by a dinucleotide deletion and reading frameshift in the region encoding the glycoprotein Ibα transmembrane domain. Blood 1997; 90: 2624-43.
146. Holmberg L, Karpman D, Nilsson I, Olofsson T. Bernard-Soulier syndrome Karlstad: Trp498→stop mutation resulting in a truncated glycoprotein Ib alpha that contains part of the transmembrane domain. Br J Haematol 1997; 98: 57-63.
147. Wright SD, Michaelides K, Johnson DJD, West NC, Tuddenham EGD. Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood 1993; 81: 2339-47.
148. Sae-Tung G, Dong JF, Lopez JA. Biosynthetic defect in platelet glycoprotein IX mutants associated with Bernard-Soulier syndrome. Blood 1996; 87: 1361-7.
149. Dinesen B, Feddersen C. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg). Throm Res 1983; 31: 707-18.
150. Clemetson JM, Kyrle PA, Brenner B, Clemetson KJ. Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. Blood 1994; 84: 1124-31.
151. Noris P, Simsek S, Stibbe J, Von dem Borne AE. A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. Br J Haematol 1997; 97: 312-20.
152. Noda M, Fujimura K, Takafuta T, Shimomura T, Fujii T, Katsutani S, Fujimoto T, Kuramoto A, Yamazaki R, Mochizuki T, Matsuzaki M, Sano M. A point mutation in glycoprotein IX coding sequence (Cys73(TGT) to Tyr(TAT) causes impaired surface expression of GP Ib/IX-V complex in two families with Bernard-Soulier syndrome. Thromb Haemost 1997; 76: 874-8.
153. Kunishima S, Lopez JA, Kobayashi S, Imai N, Kamiya T, Saito H, Naoe T. Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alpha/beta disulfide linkage in a family with giant platelet disorder. Blood 1997; 89: 2404-12.
154. Miller JL, Cunningham D, Lyle VA, Finch CL. Mutation in the gene encoding the α chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-5.